CHO Pharma (TWSE: 6586) is a pharmaceutical company that focuses on carbohydrate-related new drug development. We apply innovative glycan technology platform to develop new drugs for infectious diseases and cancers. Hence, our company employs a double-engine business model that aims at both technology platform licensing and new drug development. Our vision is to become global leading glycan technology biotechnical pharmaceutical enterprise.
Location: Taiwan, Taipei
Employees: 11-50